Search Assessments
ITAC logo
Search Assessments
Grant Funding Opportunity NOW OPEN
Up to $300k at 50% cost share for qualifying* projects.
Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received an ITAC, Onsite Energy/CHP TAP, or qualified equivalent assessment since 2018 can now apply for grants for implementation of assessment recommendations at up to 50% of qualifying* project costs with a maximum of $300,000 per grant.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
140 matching assessments
ARC 2+ Digits Required
NAICS Pharmaceutical and medicine manufacturing
SIC 2+ Digits Required
3+ Characters Required for Products
ID Year Products Rec's Plant Energy $/yr Rec'd Savings $/yr
SF0623 2024 Synthetic peptides 5 $186k $16k
UU0255 2024 Vitamins and supplements 8 $539k $99k
MI0445 2024 Pharmaceuticals 8 $3,373k $837k
MI0443 2024 Soft gels 8 $376k $65k
AS0579 2024 Nutraceuticals 7 $169k $115k
SU0551 2024 Biologics drug substance 11 $2,735k $116k
MI0439 2024 Pharmaceuticals 6 $1,040k $662k
SU0548 2024 Biologics drug substance 10 $2,278k $217k
UW2402 2024 Pharmaceutical preparation manufacturing 8 $396k $177k
MI0436 2023 Vitamins, supplements 9 $221k $3,202k
AS0566 2023 Dietary supplements 6 $100k $33k
OR0779 2023 Phase i/ii clinical trial materials, spray-dried drugs, tablets/capsules 4 $107k $54k
UU0221 2023 Nutrition supplement 7 $117k $49k
LE0546 2023 Generic drugs 9 $2,388k $170k
SD0629 2022 Processed plasma 5 $514k $73k
SD0626 2022 Antibodies, cell therapies 6 $1,516k $239k
SD0625 2022 Antibodies, cell therapies 5 $562k $113k
CC0011 2022 Active pharmaceutical ingredients 5 $549k $20k
LE0539 2022 Medical diagnostics solutions 4 $726k $44k
UD1038 2022 Pharmaceuticals 7 $1,084k $91k